What can be done in two minutes to potentially improve the lives of a billion people worldwide? See how TAEUS is empowering clinicians to improve liver health through early diagnosis of fatty liver disease: #NAFLD #NASH
Don't take alcohol but also don't take too many medecines for improving your liver. specially antifungals, paracetamol, pills and a lot of medecine when they are taken together and frequently.
CEO & Board Chair @ ENDRA Life Sciences (Nasdaq: NDRA) • MedTech Innovation • IPO • Transforming Early Detection of Liver Disease
June 13 marks Global Fatty Liver Day, a vital initiative to raise awareness about a disease that affects roughly 2 billion people worldwide. At ENDRA Life Sciences, we're pioneering Thermo Acoustic Enhanced UltraSound (TAEUS®) to assess liver fat non-invasively at 1/40th the cost of an MRI, at the point of patient care. Join us in our mission to broaden access to better healthcare and advance the diagnosis and understanding of steatotic liver disease (SLD). #FattyLiverDay #HealthcareInnovation #ENDRALifeSciences #TAEUS
CEO & Board Chair @ ENDRA Life Sciences (Nasdaq: NDRA) • MedTech Innovation • IPO • Transforming Early Detection of Liver Disease
Thrilled that ENDRA's cutting-edge technology has been installed at King's College Hospital in London, UK! 🇬🇧 This is a significant step towards advancing liver health assessment in the UK, and we are proud to be associated with such a renowned institution. https://lnkd.in/eqx6nZ9p #MASLD #SLD #NAFLD #TAEUS #ENDRALifeSciences #LiverHealth #KCH
CEO & Board Chair @ ENDRA Life Sciences (Nasdaq: NDRA) • MedTech Innovation • IPO • Transforming Early Detection of Liver Disease
High-energy 10-minute dive into the metabolic health market and evolving technologies. https://lnkd.in/ekrRK24c Thanks @Robert “Sully” Sullivan and @Mary Burt-Godwin #MASLD #ENDRA #TAEUS #SLD
CEO & Board Chair @ ENDRA Life Sciences (Nasdaq: NDRA) • MedTech Innovation • IPO • Transforming Early Detection of Liver Disease
Had a great discussion on The Wall Street Resource about Steatotic Liver Disease, approaching game-changing therapies, and the need for better diagnostics. Listen here: https://lnkd.in/eFMJYeu #ENDRA #SLD #TAEUS #MASLD
CEO & Board Chair @ ENDRA Life Sciences (Nasdaq: NDRA) • MedTech Innovation • IPO • Transforming Early Detection of Liver Disease
ENDRA's great sales team demonstrating our liver fat measurement technology at the UK Diabetes Professional Care conference. Liver fat is increasingly viewed as a primary biomarker of overall metabolic health. #endra #TAEUS #MASLD #diabetes
If you are a clinician attending AASLD and have an interest in multi-speciality management of MASLD, please join us for a lively discussion and refreshments on Sunday, November 12 at 5:30pm, with 3 stellar panelists. RSVP here: https://lnkd.in/e8yTX5Gk
Another productive day at the European Association for the Study of Diabetes in Hamburg! Our booth is getting excellent turnout from endocrinologists showing interest in hepatic steatosis as a metabolic biomarker. #EASD #diabetesresearch #metabolicbiomarkers #TAEUS #ENDRA #MAFLD #SLD
CEO & Board Chair @ ENDRA Life Sciences (Nasdaq: NDRA) • MedTech Innovation • IPO • Transforming Early Detection of Liver Disease
ENDRA's TAEUS technology on display at EASD in Hamburg. The excellent traffic we're seeing is a testament to the growing interest in liver health as a metabolic biomarker in endocrinology. #ENDRA #TAEUS #EASD #SLD #MAFLD #liverhealth #endocrinology
Octopus
2yWhen do you start market check before just adding patents. Proof of concepts?